Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Life Sciences|January 21, 1985
Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)N Castagnoli, K Chiba, A J TrevorJournal of Medicinal Chemistry|June 20, 1997
Probing the active sites of monoamine oxidase A and B with 1,4-disubstituted tetrahydropyridine substrates and inactivatorsS L Palmer, S Mabic, N CastagnoliJournal of Medicinal Chemistry|February 1, 1987
Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine delta 1'(5')-iminium speciesL A Peterson, A Trevor, N CastagnoliChemical Research in Toxicology|January 29, 2000
Isolation and characterization of a monoamine oxidase inhibitor from tobacco leavesA A Khalil, S Steyn, N CastagnoliBiochemistry|March 12, 1996
Deuterium isotope effect studies on the MAO-B catalyzed oxidation of 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridineA H Anderson, S Kuttab, N CastagnoliBiochemical and Biophysical Research Communications|May 16, 1985
Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomesK Chiba, A J Trevor, N CastagnoliBioorganic & Medicinal Chemistry|April 21, 1998
1-Methyl-3-pyrrolines and 2-methylisoindolines: new classes of cyclic tertiary amine monoamine oxidase B substratesY X Wang, S Mabic, N CastagnoliChemical Research in Toxicology|March 1, 1990
Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a nonneurotoxic analogue of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineN Naiman, H Rollema, E Johnson, et al.NIDA Research Monograph|January 1, 1978
Quantitative structure-activity relationships in the 2,4,5-ring substituted phenylisopropylaminesG M Anderson, N Castagnoli, P A kollmanJournal of Medicinal Chemistry|March 1, 1979
Metabolic oxidation of nicotine to chemically reactive intermediatesT L Nguyen, L D Gruenke, N CastagnoliPageof 16